We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Eversource Energy
ES
$26.8B
| $25.4M | 0.06% |
303,647
+55,106
| +22% | +$4.9M |
|
427
Baker Hughes
BKR
$63.6B
| $25.3M | 0.06% |
877,352
+564,519
| +180% | +$19.1M |
|
|
PINC
428
DELISTED
Premier
PINC
| $25.2M | 0.06% |
707,094
+299,557
| +74% | +$11M |
|
429
D.R. Horton
DHI
$41B
| $25.2M | 0.06% |
386,893
+81,312
| +27% | +$5.71M |
|
430
MKS Inc
MKSI
$19.8B
| $24.8M | 0.06% |
248,226
+79,332
| +47% | +$9.24M |
|
|
CHX
431
DELISTED
ChampionX
CHX
| $24.8M | 0.06% |
1,247,189
+207,976
| +20% | +$4.7M |
|
432
CMS Energy
CMS
$21.7B
| $24.7M | 0.06% |
369,137
-2,107
| -0.6% | -$145K |
|
433
Brown-Forman Class B
BF.B
$12.9B
| $24.7M | 0.06% |
351,900
+58,534
| +20% | +$3.92M |
|
434
Casey's General Stores
CASY
$31.6B
| $24.5M | 0.06% |
133,499
-13,280
| -9% | -$2.67M |
|
435
Linde
LIN
$227B
| $24.4M | 0.06% |
86,071
-32,975
| -28% | -$10.3M |
|
436
International Bancshares
IBOC
$4.53B
| $24.1M | 0.05% |
610,144
-70,438
| -10% | -$2.87M |
|
437
Equitable Holdings
EQH
$14.4B
| $23.9M | 0.05% |
933,053
+293,176
| +46% | +$8.5M |
|
438
Zoom
ZM
$31.4B
| $23.8M | 0.05% |
223,112
-25,821
| -10% | -$2.72M |
|
439
Allegion
ALLE
$14.1B
| $23.8M | 0.05% |
243,961
-247,352
| -50% | -$26.8M |
|
440
ServiceNow
NOW
$132B
| $23.8M | 0.05% |
257,930
+38,030
| +17% | +$3.62M |
|
|
DOCU
441
DocuSign
DOCU
$11.4B
| $23.8M | 0.05% |
419,252
-251,124
| -37% | -$20.3M |
|
442
Autodesk
ADSK
$54.1B
| $23.6M | 0.05% |
137,462
-15,066
| -10% | -$2.9M |
|
443
Macerich
MAC
$6.9B
| $23.5M | 0.05% |
2,766,340
+1,409,191
| +104% | +$17M |
|
444
Darling Ingredients
DAR
$9.91B
| $23.4M | 0.05% |
391,208
+89,479
| +30% | +$6.79M |
|
445
FTI Consulting
FCN
$4.17B
| $23.4M | 0.05% |
132,683
+17,964
| +16% | +$2.96M |
|
446
Trip.com Group
TCOM
$29.7B
| $23.4M | 0.05% |
851,141
-38,323
| -4% | -$855K |
|
447
Arch Capital
ACGL
$33.5B
| $23.4M | 0.05% |
525,456
-94,732
| -15% | -$4.39M |
|
448
Crane NXT
CXT
$2.96B
| $23.2M | 0.05% |
788,244
+283,100
| +56% | +$9.42M |
|
449
Murphy Oil
MUR
$5.09B
| $23.1M | 0.05% |
764,617
+463,101
| +154% | +$17.8M |
|
450
Louisiana-Pacific
LPX
$5.2B
| $23M | 0.05% |
448,592
+101,318
| +29% | +$6.5M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.